Suven to participate in 11th clinical trials on Alzheimer’s disease in Spain
Suven Life Sciences is participating and presenting the baseline patient demographics and scales from the ongoing phase-2a proof-of-concept trial of SUVN-502 for moderate Alzheimer’s Disease at 11th clinical…

